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showed extensive intraluminal mass in the pulmonary trunk and 
left pulmonary artery, diagnosed as massive pulmonary embolism. 
Since there was no clinical improvement after anticoagulant therapy, 
CT pulmonary angiography was repeated (Figure 1), and with no 
change observed in the intraluminal filling defect in pulmonary 
trunk, the possibility of tumor was raised. For further evaluation of 
a possible malignancy, F-18 FDG PET/CT was performed. It showed 
increased FDG uptake, suspicious for an aggressive tumor, in the 
intraluminal lesion of the pulmonary trunk and along the wall of 
the left pulmonary artery (Figure 2). There was no extrathoracic 
abnormality seen on PET/CT scan. Histopathological finding after 
complete pulmonary artery resection and left pneumonectomy 
showed a 9 cm long high grade undifferentiated pleomorphic 
sarcoma. No metastases were found in the parenchyma of the 
left lung. Three months after diagnosis, the patient was doing well 
and was receiving adjuvant chemotherapy treatment consisting of 
gemcitabine/docetaxel combination.
Introduction
Pulmonary artery sarcomas (PASs) are extremely rare malignant 
tumors that are usually misdiagnosed as pulmonary embolisms be-
cause of their similar symptoms and similar appearance on CT 
(computed tomography) scans as intraluminal filling defects in the 
pulmonary arteries. Due to the fact that PASs are fluorodeoxyglu-
cose F-18 (F-18 FDG) avid, F-18 FDG PET/CT (positron emission 
tomography/CT) scan is a useful imaging tool for differentiating 
malignant intraluminal mass of PAS from the intraluminal mass in 
pulmonary artery embolism, as this case shows. 
Case report
We report a case of a 60-year-old woman presented with 
a 6-month history of chest pain, dyspnea on exertion, non-productive 
cough and weight loss. The initial CT pulmonary artery angiography 
Figure 1. Repeated CT pulmonary angiography showed extensive intraluminal filling defect in the pulmonary trunk stretching from pulmonary valve 
to the bifurcation (A), with extension into the left pulmonary artery and its lobar and segmental branches (B), possible intraluminal tumor 
49www.journals.viamedica.pl/nuclear_medicine_review
Ewa Pietrzak-Stelmasiak et al., Usefulness of parametric renal clearance images
Clinical 
vignette
Figure 2. F-18 FDG PET/CT. Increased FDG uptake seen in an intraluminal lesion of the pulmonary trunk from pulmonary valve to bifurcation  
(A, SUVmax 10). Increased FDG uptake seen along the wall of the left pulmonary artery and its lobar branches (B, SUVmax 5), without intraluminal 
accumulation in that area
Conclusion
Pulmonary artery sarcomas are rare and aggresive malignant 
tumors with less then 400 individual cases reported in the litererature. 
Due to similar clinical and radiological presentation they are usually 
misdiagnosed as pulmonary embolisms. We report a case of pulmo-
nary artery sarcoma that was appropriately diagnosed with the aid of 
F-18 FDG PET/CT imaging. PET/CT has shown the ability to differenti-
ate pulmonary embolism and PAS before invasive procedures and 
at the same time enable the proper staging of the malignancy and 
help the surgeons to detect the extent of viable tumor and plan the 
appropriate therapy. Also, this case demonstrates the importance of 
maintaining a suspicion of PAS in those patients diagnosed as having 
PE whose symptoms are not improving with anticoagulation therapy. 
